How North Carolina Could Save Us All

The Federal Cannabinoid Ban is Coming. Are the States Prepared?

If the United States were ever a country based on strict adherence to the law, those days are long past. The modern game lies in devising methods to circumvent laws. It’s how the rich avoid taxes, the powerful avoid jail, and industries of all kinds bypass regulations. 

The paradox is that, despite its ubiquity, it’s not easy to stay beyond the reach of the long arm of the law. Well-moneyed, influential organizations still sometimes misjudge the political and legal playing field and have to pay up. The Sacklers (the family behind Purdue Pharma) eventually were bankrupted by the courts for their role in the opioid epidemic, and officials hit Meta with a $5 billion fine over privacy concerns. 

So how can the counterculture industry, which lacks the political clout and economic power of the elite, skirt the rules? North Carolina has a plan. Senate Bill 265 might hold the answer to how smoke shops continue to operate despite the federal countdown to perma-banning cannabinoids at the end of the month. 

If successful, the bill could be a model for the 30 other states without a well-regulated cannabinoid policy, essentially salvaging the nation’s smoke shops and keeping medical costs down for users who rely on cannabinoids for sleep, pain, or anxiety. It could also be a bright spot in another lackluster economy. Last year, cannabinoids were responsible for $4.4 billion in economic impact in North Carolina, according to Whitney Economics

What’s left to discover is whether lawmakers in the Tar Heel State will allow the full Senate to vote on the bill or if they’d prefer to stay still until the feds swing the hammer. 

 

A Short History of Nearly Everything

This problem started when President Trump signed a bill in November 2025 that ended the shutdown. One of its provisions, snuck by Sen. Mitch McConnell (R-KY), was a measure designed to close the so-called loophole in the 2018 Farm Bill that “accidentally” legalized the sales of cannabinoids like Delta 8, Delta 10, and THCA flower.

Kentucky’s other Republican senator, Rand Paul, fought hard against the inclusion, but ultimately caved after ensuring that the ban wouldn’t take effect for one year, giving states a chance to prepare. 

But, at true political speed, many states have waited until the last minute to mount a defense. 

Under the ban, which is set to go into effect Nov. 12, such cannabinoids will be declared illegal at the federal level. The move will devastate the industry, deny over-the-counter pain medicine to millions, and crash through small-town economies like a wrecking ball. 

Unless, of course, states like North Carolina move to stop it.

 

The North Carolina Answer

The brilliance behind North Carolina’s SB 265, also known as the Protecting Our Community Act, lies in its practical approach to problem-solving. If it sails through the state legislature and bypasses a veto, it will take advantage of a kind of legal gentleman’s agreement that has long governed how the feds respond to state-regulated industries. 

While national regulations are meant to override state laws, U.S. regulators tend to relax their oversight when it conflicts with specific state regulations. In other words, when states make their own rules, the feds leave them alone. It’s how we currently deal with marijuana and raw milk, which are both illegal nationally but can be bought and sold in states that have what the feds believe is sufficient regulatory structure in place. When states step up, the feds respect it. 

Importantly, the ban will only apply to states like North Carolina that don’t have robust regulations in place. Other states, such as California and Colorado, probably won’t be affected by the ban’s implementation. 

 

But Will it Pass? 

The Protecting Our Community Act has a lot going for it. For one, it was introduced with bipartisan support. Eight senators co-sponsored the bill, five Republicans and three Democrats. For another, there has so far been no meaningful public resistance to it. What’s most impressive, however, is how smartly the bill operates. 

While the phrase “common sense” often gets bandied about in political circles, it’s usually a disguise for partisan thinking. SB 265, however, earns the description. 

If passed, the bill would ensure every cannabis product undergoes independent third-party testing, raise the purchasing age to 21, mandate that products adhere to clear labeling standards, and require all sellers, growers, and distributors of cannabis to obtain state-issued licenses. Effectively, the bill would make cannabis products safer to use, harder for teens to obtain, and more difficult for gas stations and fly-by-night operations to sell. In other words, it would professionalize the state’s industry. 

The only meaningful holdup has come from a nefarious action that, unfortunately, has the power to crater the entire thing. The bill has stalled in the Senate’s Rules and Operations Committee. Before it can go to the Senate floor for a vote, it must get out of committee, but its chair, Bill Rabon, has so far refused to schedule a committee vote, even though he’s been a champion of medical marijuana. It’s likely Rabon won’t schedule a vote until Republican Senate leadership OK’s the move. 

What’s holding that up? It’s anyone’s guess. 

 

Far-Reaching Implications 

We often think of history as something that occurs slowly over many years, but it actually happens quickly, through specific moments. The 2018 Farm Bill was one history-making moment. This federal cannabinoid ban is another.  

If the bill saves North Carolina smoke shops, it will be good. But if it inspires copycat legislation in other states, it will be great. Similar responses are occurring in Georgia, Indiana, and Kentucky, while other states, such as Missouri, Virginia, and Washington state, are considering decidedly less cannabis-friendly approaches. Every bill needs help and support to push through political roadblocks. And even if they succeed, success isn’t fully guaranteed (just likely). 

For an industry that doesn’t benefit from old money or a long-respected history, handling this moment correctly matters. If the federal ban lands, millions of Americans will lose a lot more than access to Delta 8. 

Recent Articles

Blending traditional values with modernized, energetic branding, Not Ya Son’s Weed falls somewhere between the cannabis days of yore and today’s recreational cannabis boom. Not Ya Son’s Weed offers a variety of products—including pre-rolls, exotic flower, and gummies—that provide much-needed relief without being too overbearing.
The officials came for Lance Alyas once before. In 2023, they caught him in a sting, seized his merchandise, and tossed him in jail. But just seven days later, after he invoked Hawaii's version of a Freedom of Information Act request, the whole case fell apart. Alyas was released without bail, allowed to simply walk out the door. Now, he’s advocating for freedom from Hawaii’s state officials once again. Only this time, it’s not just his own freedom. As the owner of Oahu’s top-rated smoke shops, he’s fighting for everyone’s right to sell hemp products in the Aloha State.
Born Sara Benetowa in Warsaw, Poland, in 1903, Sula Benet may not be an immediately recognizable name in cannabis spaces today, but she should be. While she primarily studied Polish folk customs, Benet became known for her graduate thesis at the University of Warsaw, titled Hashish in Folk Customs and Beliefs. In the paper, she claims that the plant kaneh bosm—which is referenced throughout the Old Testament and Torah and often translated as “calamus”—actually refers to hemp. Benet’s theory remains both significant and highly controversial today, especially as various religious and evangelical groups continue to demonize the plant.
If the United States were ever a country based on strict adherence to the law, those days are long past. The modern game lies in devising methods to circumvent laws. It’s how the rich avoid taxes, the powerful avoid jail, and industries of all kinds bypass regulations. The paradox is that, despite its ubiquity, it’s not easy to stay beyond the reach of the long arm of the law. Well-moneyed, influential organizations still sometimes misjudge the political and legal playing field and have to pay up. The Sacklers (the family behind Purdue Pharma) eventually were bankrupted by the courts for their role in the opioid epidemic, and officials hit Meta with a $5 billion fine over privacy concerns.
When you walk into a smoke shop today, you might notice the glass cases that once held rolling papers and blunt wraps now display CBD tinctures, functional mushroom capsules, kava elixirs, and hemp-infused sparkling water. The staff might talk to you about terpene profiles, cortisol levels, and a new vape line.
I went home and told my girlfriend, who, after Googling the name of the business I bought it from, told me that, yes, it was technically weed. But it was CBD. She started laughing, telling me I had been ripped off.
State-sanctioned medical and recreational cannabis programs benefit the average user in many ways. Still, they remain a double-edged sword for dispensary owners, greenhouse growers, and others who earn their living from the cannabis industry. There are plenty of profits to be had, sure, but how exactly are you expected to secure your cash or process electronic transactions when banks refuse to work with you?
Aubrey Amatelli wants to help dispensaries and cannabis retailers navigate one of the toughest parts of the industry: money. When the company she worked for right out of grad school was acquired by JPMorgan, Aubrey entered the complex world of payments and has stayed there for her entire career.